Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Vimseltinib (DCC-3014) is a c-FMS (CSF-IR) and c-Kit dual inhibitor (IC50s: <0.01 μM and 0.1-1 μM).
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
無料サンプル 1 mg | |||||
1 mg | 在庫あり | ¥ 22,000 | |||
5 mg | 在庫あり | ¥ 55,000 | |||
10 mg | 在庫あり | ¥ 87,000 | |||
25 mg | 在庫あり | ¥ 147,000 | |||
50 mg | 在庫あり | ¥ 209,500 | |||
100 mg | 在庫あり | ¥ 282,500 | |||
500 mg | 在庫あり | ¥ 571,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 60,500 |
説明 | Vimseltinib (DCC-3014) is a c-FMS (CSF-IR) and c-Kit dual inhibitor (IC50s: <0.01 μM and 0.1-1 μM). |
ターゲット&IC50 | c-Kit:0.1-1 μM , c-FMS/CSF-IR:<0.01 μM |
In vitro | DCC-3014 has anti-cancer and anti-proliferative activities. |
別名 | DCC-3014 |
分子量 | 431.49 |
分子式 | C23H25N7O2 |
CAS No. | 1628606-05-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 73 mg/mL (169.18 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Vimseltinib 1628606-05-2 Tyrosine Kinase/Adaptors c-Fms c-Kit CSF-1R CSF1R CD117 CSF-1 receptor DCC 3014 SCFR inhibit DCC3014 DCC-3014 colony stimulating factor 1 receptor Inhibitor inhibitor